bf/NASDAQ:ACHL_icon.jpeg

NASDAQ:ACHL

Achilles Therapeutics

  • Stock

USD

Last Close

0.95

25/09 14:38

Market Cap

34.51M

Beta: 0.94

Volume Today

123.01K

Avg: 193.80K

PE Ratio

−0.53

PFCF: −15.51

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
asset turnover
cash per share
59.44
-
4.38
92.63%
9.29
112.28%
4.43
52.35%
3.29
25.70%
company equity multiplier
1.04
-
1.16
11.36%
1.10
5.26%
1.12
2.11%
1.13
1.41%
days of inventory outstanding
0.00
-
days of payables outstanding
days of sales outstanding
dividend yield
ebit per revenue
ebt per ebit
1.02
-
0.98
3.09%
0.95
3.36%
0.91
4.68%
0.93
2.37%
effective tax rate
-0.00
-
-0.00
570.49%
-0.00
157.77%
0.11
7,359.10%
enterprise value multiple
5.19
-
-15.49
398.40%
1.81
111.71%
1.73
4.41%
1.14
34.34%
fixed asset turnover
free cash flow per share
-9.19
-
-0.91
90.06%
-2.34
155.71%
-1.71
26.65%
-1.24
27.36%
gross profit margin
interest coverage
10.71
-
inventory turnover
4.73M
-
long term debt to capitalization
0.06
-
0.03
57.02%
0.02
16.72%
net income per ebt
1
-
1.00
0.01%
1.00
0.05%
1.00
0.10%
0.89
11.48%
net profit margin
operating cash flow per share
-8.61
-
-0.62
92.78%
-2.07
232.82%
-1.52
26.48%
-1.22
20.01%
operating profit margin
payables turnover
pretax profit margin
price fair value
0.27
-
3.55
1,224.04%
0.50
86.03%
0.18
63.95%
0.25
39.62%
receivables turnover
return on assets
-0.13
-
-0.15
14.04%
-0.19
27.05%
-0.32
67.64%
-0.43
34.10%
return on capital employed
-0.14
-
-0.17
22.66%
-0.22
29.21%
-0.39
79.80%
-0.59
51.88%
return on equity
-0.14
-
-0.18
27.00%
-0.21
20.37%
-0.36
71.17%
-0.49
35.99%
total debt to capitalization
0.00
-
0.08
1,527.50%
0.04
47.81%
0.04
2.68%
0.02
41.85%

All numbers in USD (except ratios and percentages)